natgillin/translations-raw huggingface dataset:
Regulation (EU) No 37/2010 should therefore be amended to include the substance cabergoline for bovine species.
Uredbu (EU) br. 37/2010 treba stoga izmijeniti kako bi se uključila tvar kabergolin za goveda.
It is appropriate to provide for a reasonable period of time for the stakeholders concerned to take measures that may be required to comply with the newly set MRL.
Primjereno je odrediti razuman rok u kojem će dionici poduzeti mjere koje bi mogle biti potrebne za usklađivanje s novom najvećom dopuštenom količinom rezidua.
It shall apply from 18 August 2014.
Primjenjuje se od 18. kolovoza 2014.
In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:
U tablicu 1. Priloga Uredbi (EU) br. 37/2010 po abecednom redu umeće se unos za sljedeću tvar:
‘Cabergoline
„Kabergolin
Cabergoline
Kabergolin
0,10 μg/kg
0,10 μg/kg
Prolactin inhibitor’
Inhibitor prolaktina”
0,25 μg/kg
0,25 μg/kg
0,50 μg/kg
0,50 μg/kg
0,15 μg/kg
0,15 μg/kg
Commission Implementing Regulation (EU) No 678/2014
Provedbena uredba Komisije (EU) br. 678/2014
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clopyralid, cyprodinil, fosetyl, pyrimethanil and trinexapac
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja roka valjanosti odobrenja aktivnih tvari: klopiralida, ciprodinila, fosetila, pirimetanila i trineksapaka
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
Uredbu (EU) br. 540/2011 treba stoga na odgovarajući način izmijeniti.
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Dio A Priloga Uredbi (EU) br. 540/2011 mijenja se u skladu s Prilogom ovoj Uredbi.
Part A of the Annex to Regulation (EU) No 540/2011 is amended as follows:
Dio A Priloga Uredbi (EU) br. 540/2011 mijenja se kako slijedi:
In the sixth column, expiration of approval, of row 129, clopyralid, the date of ‘30 April 2017’ is replaced by ‘30 April 2018’;
U šestom stupcu („Prestanak odobrenja”) retka 129. (klopiralid) datum „30. travnja 2017.” zamjenjuje se datumom „30. travnja 2018.”;
In the sixth column, expiration of approval, of row 130, cyprodinil, the date of ‘30 April 2017’ is replaced by ‘30 April 2018’;
U šestom stupcu („Prestanak odobrenja”) retka 130. (ciprodinil) datum „30. travnja 2017.” zamjenjuje se datumom „30. travnja 2018.”;
In the sixth column, expiration of approval, of row 131, fosetyl, the date of ‘30 April 2017’ is replaced by ‘30 April 2018’;
U šestom stupcu („Prestanak odobrenja”) retka 131. (fosetil) datum „30. travnja 2017.” zamjenjuje se datumom „30. travnja 2018.”;
In the sixth column, expiration of approval, of row 132, trinexapac, the date of ‘30 April 2017’ is replaced by ‘30 April 2018’;
U šestom stupcu („Prestanak odobrenja”) retka 132. (trineksapak) datum „30. travnja 2017.” zamjenjuje se datumom „30. travnja 2018.”;
In the sixth column, expiration of approval, of row 135, pyrimethanil, the date of ‘31 May 2017’ is replaced by ‘30 April 2018’.
U šestom stupcu („Prestanak odobrenja”) retka 135.
The approvals of the active substances clopyralid, cyprodinil, fosetyl and trinexapac will expire on 30 April 2017 and that of the active substance pyrimethanil will expire on 31 May 2017.
Odobrenja aktivnih tvari klopiralid, ciprodinil, fosetil i trineksapak prestaju važiti 30. travnja 2017., dok za aktivnu tvar pirimetanil odobrenje prestaje važiti 31. svibnja 2017.
Commission Implementing Regulation (EU) No 679/2014
Provedbena uredba Komisije (EU) br. 679/2014
Commission Implementing Regulation (EU) No 681/2014
Provedbena uredba Komisije (EU) br. 681/2014
amending Regulation (EU) No 37/2010, as regards the substance ‘rafoxanide’
o izmjeni Uredbe (EU) br. 37/2010 u pogledu tvari „rafoksanid”
Rafoxanide is currently included in Table 1 of the Annex to Regulation (EU) No 37/2010 as an allowed substance, for bovine and ovine species, applicable to muscle, fat, liver and kidney, excluding animals producing milk for human consumption.
Rafoksanid je trenutačno uvršten u tablicu 1. Priloga Uredbi (EU) br. 37/2010 kao dopuštena tvar u mišićima, masnom tkivu, jetri i bubrezima goveda i ovaca, isključujući životinje čije je mlijeko namijenjeno prehrani ljudi.
A request for an opinion on the extrapolation of the existing entry for rafoxanide applicable to bovine milk has been submitted to the European Medicines Agency.
Europskoj agenciji za lijekove podnesen je zahtjev za mišljenje o ekstrapolaciji postojećeg unosa za rafoksanid primjenljivog na kravlje mlijeko.
The Committee for Medicinal Products for Veterinary Use has recommended the establishment of a provisional MRL for rafoxanide for bovine and ovine milk and the removal of the prohibition to use that substance in animals from which milk is produced for human consumption.
Odbor za veterinarsko-medicinske proizvode preporučio je utvrđivanje privremenih NDK-ova za rafoksanid za kravlje i ovčje mlijeko te ukidanje zabrane uporabe te tvari kod životinja čije je mlijeko namijenjeno prehrani ljudi.
The entry for rafoxanide in Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended to include the recommended provisional MRL for bovine and ovine milk and to remove the prohibition to use that substance from animals from which milk is produced for human consumption.
Unos za rafoksanid u tablici 1. Priloga Uredbi (EU) br. 37/2010 treba stoga izmijeniti kako bi uključivao preporučeni privremeni NDK za kravlje i ovčje mlijeko te kako bi se ukinula zabrana uporabe te tvari kod životinja čije je mlijeko namijenjeno prehrani ljudi.
The provisional MRL for rafoxanide set out in that Table should expire on 31 December 2015.
Privremeni NDK za rafoksanid utvrđen u toj tablici trebao bi biti na snazi do 31. prosinca 2015.
It is appropriate to provide for a reasonable period of time for the stakeholders concerned to take measures that may be required to comply with the newly set MRL.
Primjereno je odrediti razuman rok u kojem će dionici poduzeti mjere koje bi mogle biti potrebne za usklađivanje s novim NDK-om.
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘rafoxanide’ is replaced by the following:
Unos za tvar rafoksanid u tablici 1. Priloga Uredbi (EU) br. 37/2010 zamjenjuje se sljedećim unosom:
‘Rafoxanide
„Rafoksanid
Rafoxanide
Rafoksanid
Antiparasitic agents/Agents against endoparasites’
Tvari protiv parazita/tvari koje djeluju protiv endoparazita”
Ovine
Ovce
Bovine, ovine
Goveda, ovce
Provisional MRL shall expire on 31 December 2015
Privremeni NDK-ovi na snazi su do 31. prosinca 2015.
Commission Implementing Regulation (EU) No 682/2014
Provedbena uredba Komisije (EU) br. 682/2014
amending Regulation (EU) No 37/2010, as regards the substance ‘closantel’
o izmjeni Uredbe (EU) br. 37/2010 u pogledu tvari „klosantel”
Closantel is currently included in Table 1 of the Annex to Regulation (EU) No 37/2010 as an allowed substance, for bovine and ovine species, applicable to muscle, fat, liver, kidney and milk.
Klosantel je trenutačno uvršten u tablicu 1. Priloga Uredbi (EU) br. 37/2010 kao dopuštena tvar u mišićima, masnom tkivu, jetri, bubrezima i mlijeku goveda i ovaca.
The provisional maximum residue limits for that substance set out for bovine and ovine milk expired on 1 January 2014.
Privremene najveće dopuštene količine rezidua te tvari utvrđene za kravlje i ovčje mlijeko nisu na snazi od 1. siječnja 2014.
Additional data were provided and assessed by the Committee for Medicinal Products for Veterinary Use who recommended that the provisional MRLs for closantel for bovine and ovine milk should be set as definitive.
Odbor za veterinarsko-medicinske proizvode dostavio je i ocijenio dodatne podatke te je predložio da se privremeni NDK-ovi za klosantel u kravljem i ovčjem mlijeku odrede kao konačni.
The entry for closantel in Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended accordingly.
Unos za klosantel u tablici 1. Priloga Uredbi (EU) br. 37/2010 stoga treba na odgovarajući način izmijeniti.
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘closantel’ is replaced by the following:
Unos za tvar klosantel u tablici 1. Priloga Uredbi (EU) br. 37/2010 zamjenjuje se sljedećim unosom:
‘Closantel
„Klosantel
Closantel
Klosantel
Commission Implementing Regulation (EU) No 683/2014
Provedbena uredba Komisije (EU) br. 683/2014
amending Regulation (EU) No 37/2010, as regards the substance ‘clorsulon’
o izmjeni Uredbe (EU) br. 37/2010 u pogledu tvari „klorsulon”
Clorsulon is currently included in Table 1 of the Annex to Regulation (EU) No 37/2010 as an allowed substance, for bovine species, applicable to muscle, liver, kidney and milk.
Klorsulon je trenutačno uvršten u tablicu 1. Priloga Uredbi (EU) br. 37/2010 kao dopuštena tvar u mišićima, jetri, bubrezima i mlijeku goveda.
The provisional maximum residue limits for that substance set out for bovine milk expired on 1 January 2014.
Privremene najveće dopuštene količine rezidua te tvari utvrđene za kravlje mlijeko nisu na snazi od 1. siječnja 2014.
Additional data were provided and assessed by the Committee for Medicinal Products for Veterinary Use who recommended that the provisional MRLs for clorsulon for bovine milk should be set as definitive.
Odbor za veterinarsko-medicinske proizvode dostavio je i ocijenio dodatne podatke te je predložio da se privremeni NDK-ovi za klorsulon u kravljem mlijeku odrede kao konačni.
The entry for clorsulon in Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended accordingly.
Unos za klorsulon u tablici 1. Priloga Uredbi (EU) br. 37/2010 stoga treba na odgovarajući način izmijeniti.
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘clorsulon’ is replaced by the following:
Unos za tvar klorsulon u tablici 1. Priloga Uredbi (EU) br. 37/2010 zamjenjuje se sljedećim unosom:
‘Clorsulon
„Klorsulon
Clorsulon
Klorsulon
Commission Implementing Regulation (EU) No 684/2014
Provedbena uredba Komisije (EU) br. 684/2014
concerning the authorisation of canthaxanthin as a feed additive for breeder hens (holder of the authorisation DSM Nutritional products Ltd)
o odobrenju kantaksantina kao dodatka hrani za kokoši za rasplod (nositelj odobrenja DSM Nutritional products Ltd.)
In accordance with Article 7 of Regulation (EC) No 1831/2003 an application was submitted for the authorisation of a canthaxanthin.
U skladu s člankom 7. Uredbe (EZ) br. 1831/2003 podnesen je zahtjev za odobrenje kantaksantina.
That application concerns the authorisation of a preparation of canthaxanthin as a feed additive for breeder hens to be classified in the additive category ‘zootechnical additives’.
Zahtjev se odnosi na odobrenje pripravka kantaksantina kao dodatka hrani za kokoši za rasplod te njegovo razvrstavanje u kategoriju dodataka „zootehnički dodaci”.
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 12 December 2012 [2] that, under the proposed conditions of use, the preparation of canthaxanthin does not have an adverse effect on animal health, human health or the environment, and that it has a potential to stabilise the reproductive performance of breeder hens.
Europska agencija za sigurnost hrane (dalje u tekstu: „Agencija”) u svojem je mišljenju od 12. prosinca 2012. [2] zaključila da pripravak kantaksantina u predloženim uvjetima uporabe nema negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš te da može stabilizirati reproduktivnu sposobnost kokoši za rasplod.
The assessment of the preparation of canthaxanthin shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Iz ocjene pripravka kantaksantina vidljivo je da su ispunjeni uvjeti za odobrenje predviđeni člankom 5. Uredbe (EZ) br. 1831/2003.
The preparation specified in the Annex, belonging to the additive category ‘zootechnical additives’ and to the functional group ‘other zootechnical additives’, is authorised as an additive in animal nutrition, subject to the conditions laid down in that Annex.
Pripravak definiran u Prilogu, koji pripada kategoriji dodataka za životinje „zootehnički dodaci” i funkcionalnoj skupini „ostali zootehnički dodaci”, odobrava se kao dodatak hrani za životinje pod uvjetima utvrđenima u Prilogu.
EFSA Journal 2013;
EFSA Journal (2013.);
Maximum residues limits in the relevant foodstuffs of animal origin
Najveće dopuštene količine rezidua (NDK) u odgovarajućoj hrani životinjskog podrijetla
DSM Nutritional products Ltd, represented by DSM Nutritional Products Sp. z o.o.
DSM Nutritional Products Ltd kojeg zastupa DSM Nutritional products Sp. Z.o.o.
Canthaxanthin
Kantaksantin
Preparation containing minimum:
Pripravak koji sadržava najmanje:
10 % of canthaxanthin;
10 % kantaksantina;
≤ 2,2 % ethoxyquin;
≤ 2.2 % etoksikvina;
dichloromethane:
diklormetan:
≤ 10 mg/kg additive.
≤ 10 mg/kg dodatka.
canthaxanthin
kantaksantin
Assay:
Sadržaj:
Minimum 96 %
najmanje 96 %
Analytical method [1]
Analitička metoda [1]
For the determination of canthaxanthin in the feed additive:
Za određivanje kantaksantina u dodatku hrani za životinje:
spectrophotometry (426 nm)
spektrofotometrija (426 nm)
For the determination of canthaxanthin in premixtures and feedingtuffs:
Za određivanje kantaksantina u premiksima i krmnim smjesama:
Normal Phase High Performance Liquid Chromatography coupled to VIS detection (NP-HPLC-VIS, 466 nm)
tekućinska kromatografija visoke djelotvornosti normalnih faza povezana s vidljivom spektroskopijom (NP-HPLC-VIS, 466 nm)
Breeder hens
Kokoši za rasplod
In the directions for use of the additive and premixture, indicate the storage conditions and stability to heat processing.
U uputama za uporabu dodatka hrani za životinje i premiksa potrebno je navesti uvjete skladištenja i stabilnost pri toplinskoj obradi.
The mixture of different sources of canthaxanthin shall not exceeded 6 mg canthaxanthin/kg of complete feedingstuff.
Mješavina različitih izvora kantaksantina ne premašuje 6 mg/kg potpune krmne smjese.
The mixture of this preparation with canthaxanthin and other carotenoids is allowed provided that the total concentration of the mixture does not exceed 80 mg/kg of complete feedingstuff.
Miješanje tog pripravka s kantaksantinom i ostalim karotenoidima dopuštena je ako ukupna koncentracija mješavine ne prelazi 80 mg/kg potpune krmne smjese.
10 July 2024
10. srpnja 2024.
15 mg canthaxanthin/kg liver (wet tissue) and 2,5 mg canthaxanthin/kg skin/fat (wet tissue)
15 mg kantaksantina/kg jetra (mokro tkivo) i 2,5 mg kantaksantina/kg koža/masno tkivo (mokro tkivo)
Details of the analytical methods are available at the following address of the European Union Reference Laboratory for Feed Additives:
Podaci o analitičkim metodama dostupni su na sljedećoj adresi referentnog laboratorija Europske unije za dodatke hrani za životinje:
www.irmm.jrc.be/eurl-feed-additives
www.irmm.jrc.be/eurl-feed-additives.
other zootechnical additives (stabilisation of reproductive performance)
ostali zootehnički dodaci (stabilizacija reproduktivne sposobnosti)
For user safety: breathing protection, safety glasses and gloves should be worn during handling.
Radi sigurnosti korisnika pri rukovanju je potrebno upotrebljavati zaštitu za dišne organe te zaštitne naočale i rukavice.
Commission Regulation (EU) No 685/2014
Uredba komisije (EU) br. 685/2014
amending Annex II to Regulation (EC) No 1333/2008 of the European Parliament and of the Council and the Annex to Commission Regulation (EU) No 231/2012 as regards polyvinyl alcohol-polyethylene glycol-graft-co-polymer in solid food supplements
o izmjeni Priloga II. Uredbi (EZ) br. 1333/2008 Europskog parlamenta i Vijeća i Priloga Uredbi Komisije (EU) br. 231/2012 u pogledu uporabe polivinil alkohol-polietilen glikol-graft-kopolimera u dodacima prehrani u krutom obliku
Having regard to Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives [1], and in particular Article 10(3) and Article 14 thereof,
uzimajući u obzir Uredbu (EZ) br. 1333/2008 Europskog parlamenta i Vijeća od 16. prosinca 2008. o prehrambenim aditivima [1], a posebno njezin članak 10. stavak 3. i članak 14.,
Commission Regulation (EU) No 231/2012 [3] lays down specifications for food additives that are listed in Annexes II and III to Regulation (EC) No 1333/2008.
Uredbom Komisije (EU) br. 231/2012 [3] utvrđuju se specifikacije za prehrambene aditive navedene u prilozima II. i III. Uredbi (EZ) br. 1333/2008.
Those lists may be updated in accordance with the common procedure referred to in Article 3(1) of Regulation (EC) No 1331/2008, either on the initiative of the Commission or following an application.
Ti popisi mogu se ažurirati u skladu sa zajedničkim postupkom iz članka 3. stavka 1. Uredbe (EZ) br. 1331/2008 na poticaj Komisije ili nakon podnošenja zahtjeva.
On 13 September 2011, an application was submitted for authorisation of the use of polyvinyl alcohol-polyethylene glycol-graft-co-polymer (PVA-PEG graft co-polymer) in aqueous instant-release film coatings for food supplements.
Dana 13. rujna 2011. podnesen je zahtjev za odobrenje uporabe polivinil alkohol-polietilen glikol-graft-kopolimera (PVA-PEG graft kopolimer) u ovojnicama za dodatke prehrani koje se brzo otapaju u vodi.
The European Food Safety Authority evaluated the safety of PVA-PEG graft co-polymer when used as a food additive and concluded that its use in food supplements as film coating is of no safety concern for the proposed uses [4].
Europska agencija za sigurnost hrane ocijenila je sigurnost PVA-PEG graft kopolimera kada se upotrebljava kao prehrambeni aditiv i zaključila da predložena uporaba PVA-PEG graft kopolimera kao sredstva za oblaganje ne predstavlja sigurnosni rizik za predložene uporabe [4].
PVA-PEG graft co-polymer is intended for use in aqueous instant-release film coatings for food supplements.
PVA-PEG graft kopolimer namijenjen je za uporabu u ovojnicama za dodatke prehrani koje se brzo otapaju u vodi.
It protects against unpleasant tastes or odours, improves appearance, makes tablets easier to swallow, gives a distinctive appearance, and protects sensitive active ingredients.
On štiti od neugodnih okusa i mirisa, poboljšava izgled, olakšava gutanje tableta, daje poseban izgled i štiti osjetljive aktivne sastojke.
A specific property of the substance is that it is extremely flexible, has low viscosity, and dissolves rapidly in acidic, neutral, and alkaline aqueous media.
Posebna svojstva tvari jesu izuzetna fleksibilnost, niska viskoznost i laka topljivost u kiselim, neutralnim i lužnatim vodenim medijima.
It is therefore appropriate to authorise the use of PVA-PEG graft co-polymer as a glazing agent in solid food supplements and to assign E 1209 as E-number to that additive.
Iz tog je razloga prikladno odobriti uporabu PVA-PEG graft kopolimera kao sredstva za glaziranje u dodacima prehrani u krutom obliku i dodijeliti PVA-PEG graft kopolimeru E-broj E 1209.
The specifications for PVA-PEG graft co-polymer should be included in Regulation (EU) No 231/2012 when it is included in the Union lists of food additives laid down in Annex II to Regulation (EC) No 1333/2008 for the first time.
Specifikacije za PVA-PEG graft kopolimer treba uvrstiti u Uredbu (EU) br. 231/2012 kada se prvi put uvrsti u popis prehrambenih aditiva Unije utvrđen Prilogom II. Uredbi (EZ) br. 1333/2008.
EFSA Journal 2013;
EFSA Journal 2013.;
in Part B, point 3 ‘Additives other than colours and sweeteners’, the following new entry is inserted after the entry for food additive E 1208 Polyvinylpyrrolidone-vinyl acetate copolymer:
U dijelu B, točki 3. „Aditivi osim bojila i sladila”, sljedeći novi unos umeće se nakon unosa za prehrambeni aditiv E 1208 Kopolimer polivinilpirolidon-vinil acetat:
‘E 1209
„E 1209
Polyvinyl alcohol-polyethylene glycol-graft-co-polymer’
Polivinil alkohol-polietilen glikol-graft-kopolimer”
in Part E, in food category 17.1 ‘Food supplements supplied in a solid form including capsules and tablets and similar forms, excluding chewable forms’, the following new entry is inserted after the entry for food additive E 1208:
U dijelu E, u kategoriji hrane 17.1 „Dodaci prehrani u krutom obliku uključujući kapsule i tablete i slične oblike, osim oblika za žvakanje”, sljedeći novi unos umeće se nakon unosa za prehrambeni aditiv E 1208:
Polyvinyl alcohol-polyethylene glycol-graft-co-polymer
Polivinil alkohol-polietilen glikol-graft-kopolimer
In the Annex to Regulation (EU) No 231/2012, the following new entry is inserted after the entry for E 1208 (Polyvinylpyrrolidone-vinyl acetate copolymer):
U Prilogu Uredbi (EU) br. 231/2012 umeće se sljedeći novi unos nakon unosa za E 1208 (Kopolimer polivinilpirolidon-vinil acetat):
‘E 1209 POLYVINYL ALCOHOL-POLYETHYLENE GLYCOL-GRAFT-COPOLYMER
„E 1209 POLIVINIL ALKOHOL-POLIETILEN GLIKOL-GRAFT-KOPOLIMER
Macrogol poly(vinyl alcohol) grafted co-polymer;
Makrogol poli(vinil alkohol) graftirani kopolimer;
poly(ethan-1,2-diol-graft-ethanol);
poli(etan-1,2-diol-graft-etanol);
ethenol, polymer with oxirane, graft;
etenol, polimer s oksiranom, graft;
oxirane, polymer with ethanol, graft;
oksiran, polimer s etanolom, graft;
ethylene oxide-vinyl alcohol graft co-polymer
etilen oksid-vinil alkohol graft kopolimer
Polyvinyl alcohol-polyethylene glycol-graft-co-polymer is a synthetic co-polymer that consists of approximately 75 % PVA units and 25 % PEG units.
Polivinil alkohol-polietilen glikol-graft-kopolimer jest sintetički kopolimer koji sadržava približno 75 % jedinica PVA i 25 % jedinica PEG.
40000 to 50000 g/mol
40000 do 50000 g/mol
White to faintly yellow powder
Prašak bijele do blago žute boje
Freely soluble in water and dilute acids and dilute solutions of alkali hydroxides;
Slobodno topljiv u vodi i razrijeđenim kiselinama i otopinama alkalijskih hidroksida;
practically insoluble in ethanol, acetic acid, acetone, and chloroform
gotovo netopljiv u etanolu, octenoj kiselini, acetonu i kloroformu
IR Spectrum
Infracrveni spektar
Must comply
Mora ispunjavati
5,0-8,0
5,0 – 8,0
Ester Value
Esterski broj
10 to 75 mg/g KOH
10 do 75 mg/g KOH
Dynamic viscosity
Dinamička viskoznost
50 to 250 mPa·s
50 do 250 mPa·s
Not more than 5 %
Najviše 5 %
Sulphated Ash
Sulfatni pepeo
Vinyl Acetate
Vinil acetat
Not more than 20 mg/kg
Najviše 20 mg/kg
Acetic acid/Total Acetate
Octena kiselina/ukupno acetata
Not more than 1,5 %
Najviše 1,5 %
Ethylene glycol
Etilen glikol
Diethylene glycol
Dietilen glikol
1,4-Dioxane
1,4-dioksan
Not more than 10 mg/kg
Najviše 10 mg/kg
Not more than 0,2 mg/kg
Najviše 0,2 mg/kg
Commission Regulation (EU) No 686/2014
Uredba Komisije (EU) br. 686/2014
amending Regulations (EC) No 983/2009 and (EU) No 384/2010 as regards the conditions of use of certain health claims related to the lowering effect of plant sterols and plant stanols on blood LDL-cholesterol
o izmjeni uredaba (EZ) br. 983/2009 i (EU) br. 384/2010 u pogledu uvjeta za uporabu određenih zdravstvenih tvrdnji koje se odnose na učinak biljnih sterola i biljnih stanola na snižavanje LDL-kolesterola u krvi
Regulation (EC) No 1924/2006 provides that applications for authorisations of health claims are to be sent to the national competent authority of the respective Member State.
Uredbom (EZ) br. 1924/2006 predviđa se da se zahtjevi za odobravanje zdravstvenih tvrdnji šalju nadležnom nacionalnom tijelu predmetne države članice.
The national competent authority is to forward those applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’.
Nadležno nacionalno tijelo prosljeđuje te zahtjeve Europskoj agenciji za sigurnost hrane (EFSA), dalje u tekstu „Agencija”.
The Authority is to give an opinion on the health claim and to forward it to the Commission who is to decide on the authorisation of the health claim taking into account the opinion delivered by the Authority.
Agencija daje mišljenje o zdravstvenoj tvrdnji i prosljeđuje ga Komisiji koja odlučuje o odobravanju zdravstvene tvrdnje uzimajući u obzir mišljenje koje je dostavila Agencija.